Dr. Kevin Kip Appointed to FDA Advisory Panel on Circulatory System Devices
Kevin E. Kip, PhD, FAHA, Professor and Executive Director for the Research Center at the University of South Florida College of Nursing was appointed as Special Government Employee (SGE) by the U.S. Food and Drug Administration (FDA) to serve in the FDA Advisory Committee, Circulatory System Devices Panel, and Center for Devices and Radiology Health.
Recently, Dr. Kip attended an FDA Scientific Advisory Panel on the safety and effectiveness of atrial septal defect (ASD) occluders, which is a form congenital heart defect that undesirably allows blood to travel from the left side of the heart to the right side of the heart, or vice versa. According to Dr. Kip, this heart defect is often called “hole in the heart.” The purpose of the meeting was to review the safety and effectiveness of 2 FDA-approved ASD occluder devices manufactured by St. Jude Medical and the W.L. Gore and Associates.
Dr. Kip will serve as a voting member for four years.